Dr. Rodriguez Valdes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Icahn School of Medicine at Mount Sinai
1 Gustave L Levy Pl
New York, NY 10029Phone+1 336-716-5847
Summary
- .
Education & Training
- University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
- Texas Tech University Health Sciences Center Paul L. Foster School of MedicineResidency, 2006 - 2009
- Monterrey Inst TechClass of 2005
- ITESM MD
Certifications & Licensure
- FL State Medical License 2022 - Present
- NY State Medical License 2021 - 2026
- NC State Medical License 2015 - 2021
- KY State Medical License 2009 - 2016
Publications & Presentations
PubMed
- Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapse.Peter Voorhees, Vera Suman, Yvonne Efebera, Noopur Raje, Sascha Tuchman
Blood Advances. 2024-10-08 - Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethas...Rebecca Silbermann, Jacob Laubach, Jonathan L Kaufman, Douglas W Sborov, Brandi Reeves
American Journal of Hematology. 2024-07-01 - 28 citationsIVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies.Guido Lancman, Kian Parsa, Krzysztof Kotlarz, Lisa Avery, Alaina Lurie
Blood Cancer Discovery. 2023-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: